Proteostasis Therapeutics raised $37,000,000 on , from Cormorant Asset Management, Elan ....

Get alertedif Proteostasis Therapeutics gets funded!
Amount:$37,000,000
Company:
Investors:, , , , , , , ,
Industry:Biotechnology
Country:
State:
City:
United States
Massachusetts
Cambridge
Key people:Michael Casey (Executive Officer)
Meenu Chhabra (Executive Officer)
Jeffrey Goldberg (Executive Officer)
Peter H. Reinhart (President and Chief Scientific Officer)
MARKUS HAEBERLEIN (Executive Officer)
Mark J. Enyedy (CEO)
M. James Barrett (Boards of Directors)
WALTER NEWMAN (Executive Officer)
Lauren Silverman (Board of Directors, Director)
JANET SMART (Executive Officer)
Data sources:
www.owler.com - Proteostasis Therapeutics received $37M in Series B Funding https://t.co/8t78OexwZ9
cysticfibrosisnewstoday.com - Proteostasis Therapeutics Secures $37 Million in New Financing for Cystic Fibrosis Treatment Development http://t.co/IsgOprSjoA
Description:
Proteostasis Therapeutics, a Biotechnology enterprise located in Cambridge, United States, closed on a 37M securities offering in 2015, September 8th.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!